As winter sets in, rhinoviruses become active, bringing with them the common cold. While some individuals barely notice these infections, others endure days of discomfort characterized by congestion and coughing.
Recent studies indicate that the differences in cold experiences may begin the moment a person is exposed to the virus. Research conducted by Yale University reveals that the initial cellular responses in the nasal lining, triggered within hours of exposure, can significantly influence the severity of a cold, often more so than the virus itself.
The Innovative Lab-Grown Nose
Rhinoviruses have a unique preference for humans, making them challenging to study in laboratory animals. To overcome this obstacle, Ellen Foxman and her research team at the Yale School of Medicine developed a human nose model.
Foxman noted, "This model provides a more accurate representation of human responses compared to traditional cell lines used in virology studies. Since rhinoviruses primarily cause illness in humans, organotypic models of human tissues are invaluable for understanding this virus."
In their research published in Cell Press Blue, the team utilized lab-grown human nasal tissue to observe the early cellular responses to a strain known as RV-A1 through single-cell RNA sequencing. Their findings indicated that the infection's outcome hinges on a protein called interferon.
Interferons serve as the immune system's "silent alarm." When nasal cells activate these proteins promptly, the infection remains limited, affecting less than 2% of the tissue. Conversely, when this interferon response is hindered, the virus can proliferate, infecting over 30% of the cells.
The Interferon Dynamics
This study suggests that the severity of cold symptoms is not solely determined by the virus but is significantly influenced by the body's reaction to it.
When the interferon response is delayed, cells enter an "inflammatory mode," releasing IL-1β, a signal that prompts increased mucus production and slows down ciliary movement. Essentially, the body gears up for an infection, which can exacerbate symptoms while still keeping the virus in check.
The researchers identified a specific molecular trigger for this response: a protein known as NLRP1. By inhibiting this protein, they could alleviate unpleasant symptoms without directly targeting the virus.
Given the commonality of colds, these findings hold significant implications, especially for individuals who are vulnerable or have compromised immune systems.
"As the leading cause of common colds and a major contributor to respiratory issues in those with asthma and other chronic lung diseases, rhinoviruses play a crucial role in human health," stated Ellen Foxman, the study's senior author.
Implications for Individuals
This new perspective indicates that the symptoms associated with the common cold, such as congestion and cough, may not always be appropriate responses; they could stem from the body overreacting.
However, the researchers caution that the nasal organoids used in the study lack some immune cell types present in a real nose, which can both help eliminate viruses and amplify inflammation. Future research will need to integrate these aspects.
Nonetheless, this study sheds light on why the same rhinovirus can cause a mild infection in one person while leading to significant discomfort in another. If the nasal cells activate their defenses early, the virus may not have the opportunity to spread.